comparemela.com

Latest Breaking News On - Davidm schuster - Page 1 : comparemela.com

New imaging tool is lighting up prostate cancer

Prostate cancer is the second most common cancer in men, with over 288,000 new cases diagnosed each year. It’s also one of the most curable cancers if detected early.

Davidm schusterWinship cancer institute of emory universityWinship cancer instituteEmory universityMorning showProstate cancer

Health Beat: Lighting up prostate cancer

A new imaging tool is transforming the way doctors detect and manage prostate cancer.

Davidm schusterWinship cancer institute of emory universityWinship cancer instituteEmory universityGet scanMedical imagingProstate cancer

U S FDA Approves Blue Earth Diagnostics POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

POSLUMA will be commercially available in the United States in early June 2023

United statesScintomics gmbDavidm schusterShelby moneerDavide gaudenBrianf chapinWinship cancer institute of emory universityEmory university school of medicineDivision of surgeryDrug administrationUniversity of texas md anderson cancer centerA siemens healthineers companyDepartment of urologyTechnical university of munichSolutions incBlue earth diagnostics

FDA Approves Imaging Agent With Radiohybrid Technology to Identify Location, Extent of Prostate Cancer

The radiohybrid imaging agent allowed positron emission tomography to identify prostate cancer with an 83% detection rate.

United statesBrianf chapinDavidm schusterDavide gaudenDivision of surgeryDepartment of urologyUniversity of texas md anderson cancer centerWinship cancer institute at emory universityEmory university school of medicineBlue earth diagnosticsAdobe stockCancer centerEmory university schoolWinship cancer institute

U S FDA Approves Blue Earth Diagnostics POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

- POSLUMA will be commercially available in the United States in early June 2023 - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative

United kingdomUnited statesClare gidleyMike beyerPriscilla harlanShelby moneerDavidm schusterBrianf chapinScintomics gmbDavide gaudenTechnical university of munichNuclear medicineDrug administrationDepartment of urologyEmory university school of medicineCorporate communications

vimarsana © 2020. All Rights Reserved.